The brand name for dabigatran etexilate is Pradaxa. [1]
What is Pradaxa used for?
Pradaxa is used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used to treat venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE in patients who have been treated for VTE. [1]
How does dabigatran etexilate work?
Dabigatran etexilate is a direct thrombin inhibitor. It works by blocking the action of thrombin, a protein that plays a key role in blood clot formation. By inhibiting thrombin, dabigatran etexilate reduces the ability of blood to form clots. [1]
When does Pradaxa's patent expire?
Information regarding the specific patent expiry dates for Pradaxa can be found through resources like DrugPatentWatch.com. [2] Patent expiry is a critical factor in determining when generic versions of the drug may become available.
Can generic versions of Pradaxa be made?
Once the patents and any periods of market exclusivity expire, generic manufacturers can apply to produce and sell their own versions of dabigatran etexilate. These generic versions would be bioequivalent to the brand-name drug, Pradaxa. [3]
Who manufactures Pradaxa?
Pradaxa is manufactured by Boehringer Ingelheim. [1]
What are the risks associated with Pradaxa?
The most serious risk associated with Pradaxa is bleeding. This can occur anywhere in the body and can be life-threatening. Patients taking Pradaxa should seek immediate medical attention if they experience any signs of bleeding, such as unusual bruising, prolonged nosebleeds, coughing up blood, or blood in urine or stool. [1]
How does Pradaxa compare to other blood thinners?
Dabigatran etexilate (Pradaxa) is one of several oral anticoagulant medications available. Other classes of anticoagulants include warfarin, as well as newer direct oral anticoagulants (DOACs) such as rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa). Each of these medications has its own specific mechanisms of action, dosing regimens, monitoring requirements, and risk profiles for bleeding and other side effects. [4]
What are the alternatives to Pradaxa?
Alternatives to Pradaxa for preventing stroke in atrial fibrillation and treating venous thromboembolism include warfarin and other DOACs like rivaroxaban, apixaban, and edoxaban. The choice of anticoagulant depends on individual patient factors, including medical history, other medications, and physician recommendations. [4]
What is the cost of Pradaxa?
The cost of Pradaxa can vary depending on factors such as insurance coverage, pharmacy, and dosage. Information on pricing and potential savings programs may be available through the manufacturer or pharmacy benefit managers. [5]
How is dabigatran etexilate administered?
Dabigatran etexilate is taken orally in capsule form. [1]
Sources:
[1] https://www.drugs.com/pradaxa.html
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/about-fda/center-drug-evaluation-and-research/generics-everything-you-need-know
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749173/
[5] https://www.goodrx.com/pradaxa